In contrast, the cell destruction process evolves slower in patients presented with an ischemic stroke, thus leading to a delayed release of GFAP (typically between 6–12 h poststroke) and differentiating between the two main types of stroke [33,34]. This evidence concerns the gene GFAP and Stroke.